38P Stock Overview
Provides social, healthcare, and wellbeing services in Finland. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Pihlajalinna Oyj Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €10.90 |
52 Week High | €11.25 |
52 Week Low | €6.78 |
Beta | 0.35 |
11 Month Change | 10.10% |
3 Month Change | 12.84% |
1 Year Change | 48.30% |
33 Year Change | -10.51% |
5 Year Change | -29.22% |
Change since IPO | -20.15% |
Recent News & Updates
Recent updates
Shareholder Returns
38P | DE Healthcare | DE Market | |
---|---|---|---|
7D | 2.8% | 0.1% | -0.02% |
1Y | 48.3% | 17.2% | 8.2% |
Return vs Industry: 38P exceeded the German Healthcare industry which returned 17.2% over the past year.
Return vs Market: 38P exceeded the German Market which returned 8.2% over the past year.
Price Volatility
38P volatility | |
---|---|
38P Average Weekly Movement | 4.4% |
Healthcare Industry Average Movement | 4.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 38P has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 38P's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 6,505 | Tuomas Hyyrylainen | www.pihlajalinna.fi |
Pihlajalinna Oyj provides social, healthcare, and wellbeing services in Finland. It offers general practitioner and medical specialist, occupational healthcare, social and healthcare outsourcing, fitness center, responsible doctor, and remote consultation services, as well as residential and staffing services. The company also provides dental care, diagnostics, and rehabilitation services.
Pihlajalinna Oyj Fundamentals Summary
38P fundamental statistics | |
---|---|
Market cap | €248.39m |
Earnings (TTM) | €13.03m |
Revenue (TTM) | €705.52m |
19.1x
P/E Ratio0.4x
P/S RatioIs 38P overvalued?
See Fair Value and valuation analysisEarnings & Revenue
38P income statement (TTM) | |
---|---|
Revenue | €705.52m |
Cost of Revenue | €535.99m |
Gross Profit | €169.53m |
Other Expenses | €156.50m |
Earnings | €13.03m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
Earnings per share (EPS) | 0.58 |
Gross Margin | 24.03% |
Net Profit Margin | 1.85% |
Debt/Equity Ratio | 71.9% |
How did 38P perform over the long term?
See historical performance and comparison